3,5-二硝基苯甲酸甲酯 | 2702-58-1

• 物质功能分类: 化学试剂 - 有机试剂 - 硝基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3,5-二硝基苯甲酸甲酯
• 中文别名: S(-)-α-甲基苄胺；乙酰环丙孕酮醋酸酯
• 英文名称: methyl 3,5-dinitrobenzoate
• 英文别名: 3,5-dinitrobenzoic acid methyl ester
• CAS: 2702-58-1
• 化学式: C₈H₆N₂O₆
• mdl: MFCD00017016
• 分子量: 226.145
• InChiKey: POGCCFLNFPIIGW-UHFFFAOYSA-N

物化性质

• 熔点：
  107-109 °C (lit.)
• 沸点：
  367.74°C (rough estimate)
• 密度：
  1.6136 (rough estimate)
• 保留指数：
  1690;1694;1701;1714;1724;1745
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  118
• 氢给体数：
  0
• 氢受体数：
  6

安全信息

• 危险品标志：
  Xn
• 安全说明：
  S24/25
• 危险类别码：
  R22
• WGK Germany：
  3
• 海关编码：
  2916399090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  存于阴凉干燥处。

SDS

Name:	Methyl 3 5-dinitrobenzoate 99% Material Safety Data Sheet
Synonym:
CAS:	2702-58-1

Section 1 - Chemical Product MSDS Name:Methyl 3 5-dinitrobenzoate 99% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
2702-58-1	Methyl 3,5-dinitrobenzoate	99	220-289-9

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 2702-58-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 107 - 109 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H6N2O6
Molecular Weight: 226.15

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 2702-58-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Methyl 3,5-dinitrobenzoate - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 2702-58-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 2702-58-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2702-58-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途：用于有机合成中间体。

反应信息

• 作为反应物：
  描述：

  3,5-二硝基苯甲酸甲酯 在 aluminum (III) chloride 、 sodium tetrahydroborate 、 palladium 10% on activated carbon 、 三氟化硼乙醚 、 氢气 、 三溴化硼 、 三乙胺 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 28.0h， 生成 N-(3-benzyl-5-hydroxyphenyl)acetamide
  参考文献：
  名称：

  设计，合成和生物学评价米-amidophenol衍生物作为一类新的抗结核剂的†

  摘要：

  一系列的米-amidophenol衍生物（6A-6L，图7a-7Q，图9a，图9b，图12A-12C，14和15），设计并合成。他们的抗结核活性进行了评价在体外对结核分枝杆菌菌株和杆菌H37Ra和H37Rv的临床分离耐多药的结核分枝杆菌菌株。十种化合物在2.5μgmL -1以下对结核分枝杆菌H37Ra表现出最低抑菌浓度（MICs），而6g是活性最高的化合物（MIC = 0.625μgmL -1）。化合物6g和7a还显示出对结核分枝杆菌H37Rv （MIC = 0.39μgmL -1）和几种临床分离的耐多药结核分枝杆菌菌株（MIC = 0.39-3.125μgmL -1）的有效抑制活性。该化合物对正常的革兰氏阳性和革兰氏阴性细菌没有抑制活性。他们表现出对HepG2和RAW264.7细胞系的低细胞毒性。结果表明米-amidophenol作为新的抗结核药物开发有吸引力的支架。

  DOI：

  10.1039/c8md00212f
• 作为产物：
  描述：

  在 3-三甲基甲硅烷基-2-噁唑烷酮 、 二溴三苯基膦 作用下， 以 二氯甲烷 为溶剂， 反应 0.42h， 生成 3,5-二硝基苯甲酸甲酯
  参考文献：
  名称：

  Aizpurua, Jesus Mari; Palomo, Claudio, Synthesis, 1982, # 8, p. 684 - 686

  摘要：

  DOI：

文献信息

• Design of photoaffinity labeling probes derived from 3,4,5-trimethylfuran-2(5 H )-one for mode of action elucidation
  作者：Martin Pošta、Vilmos Soós、Petr Beier

  DOI：10.1016/j.tet.2016.03.096

  日期：2016.7

  Herein we report the synthesis of new probes for photoaffinity labeling with the aim of receptor identification and mode of action elucidation of 3,4,5-trimethylfuran-2(5H)-one (TMB), recently identified in the smoke of burning vegetation as an efficient seed germination inhibitor. These photoaffinity probes consist of an ethynyl group that acts as a tag for introduction of an optional detectable marker

  本文中，我们报道了新的用于亲和标记的探针的合成，其目的是为了识别受体，并阐明3,4,5-trimethylfuran-2（5 H）-one（TMB）的作用方式，最近在燃烧的植被中发现了这种烟雾作为有效的种子发芽抑制剂。这些光亲和探针由乙炔基组成，该乙炔基充当标签，用于在光交联操作后通过适当的化学选择性连接方法引入可选的可检测标记单元。
• Zinc phthalocyanine with PEG-400 as a recyclable catalytic system for selective reduction of aromatic nitro compounds
  作者：Upendra Sharma、Neeraj Kumar、Praveen Kumar Verma、Vishal Kumar、Bikram Singh

  DOI：10.1039/c2gc35452g

  日期：——

  for the first time. The present catalytic system was successfully employed for the reduction of carbonyl and ester compounds to corresponding alcohols and reductive amination of benzaldehydes with primary amines to form corresponding secondary amines. Remarkable advantages of the present catalytic method include low loading of metal, avoidance of toxic ligands and high isolated yields. The catalyst was

  建立了带有PEG-400的酞菁锌作为催化体系，用于将芳香族硝基化合物化学和区域选择性还原为相应的胺。很好地耐受各种可还原的官能团，例如酸，酰胺，酯，卤素，内酯，腈，N-苄基，O-苄基，羟基和杂环。由O直接合成苯并三唑-二硝基苯是首次获得的。本催化体系已成功地用于将羰基和酯化合物还原成相应的醇，以及将苯甲醛与伯胺还原胺化以形成相应的仲胺。本催化方法的显着优点包括金属的低负载，避免有毒的配体和高的分离产率。催化剂可循环使用多达四次，而不会损失任何选择性和活性。
• Synthesis and Evaluation of Some Substituted Heterocyclic Fluconazole Analogues as Antifungal Agents
  作者：Shudong Wang、Lei Zhang、Yongsheng Jin、Jin Hao Tang、Hua Su、Shichong Yu、Haixiang Ren

  DOI：10.14233/ajchem.2014.15956

  日期：——

  A new series of fluconazole analogues of 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluoro-phenyl)-3-4-(substituted-heterocyclic ring-1H-1,2,3-triazol-1-yl)-2-propanols (1-10) were designed, synthesized and evaluated as antifungal agents. Preliminary antifungal tests showed that most of the title compounds exhibited moderate activity with broad spectrum against eight human pathogenic fungi in vitro, compounds 1 and 6 had the best antifungal activity against Candida albicans with the value of MIC80 = 0.5 μg/mL respectively.

  设计、合成了1-(1H-1,2,4-三唑-1-基)-2-(2,4-二氟苯基)-3-4-(取代杂环-1H-1,2,3-三唑-1-基)-2-丙醇(1-10)系列氟康唑类似物，并评价了其抗真菌活性。初步抗真菌测试显示，大多数标题化合物对8种人体致病真菌具有中等活性且谱广，其中化合物1和6对白色念珠菌显示出最佳的抗真菌活性，MIC80值分别达到0.5 μg/mL。
• [EN] (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING<br/>[FR] DÉRIVÉS DE (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE ET COMPOSÉS ASSOCIÉS UTILISÉS EN TANT QU'INHIBITEURS DE LA BÊTA-SÉCRÉTASE POUR LE TRAITEMENT
  申请人：COMENTIS INC

  公开号：WO2009042694A1

  公开（公告）日：2009-04-02

  The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)

  本发明提供了新颖的β-分泌酶抑制剂及其使用方法，包括用于治疗阿尔茨海默病的方法。
• Relative reactivity of methyl iodide to ethyl iodide in nucleophilic substitution reactions in acetonitrile and partial desolvation accompanying activation
  作者：Yasuhiko Kondo、Miyuki Urade、Yukari Yamanishi、Xinyu Chen

  DOI：10.1039/b203032m

  日期：——

  have been deduced on the basis of these classifications. A major factor determining the relative reactivity of methyl iodide to ethyl iodide in the substitution reaction of an anionic nucleophile having a single reaction site in acetonitrile (kMeI/kEtI) is suggested to be partial desolvation around the nucleophilic center on going from reactant to transition-state.

  通过检验涉及的经验相关性 激活 亲核取代的参数 甲基碘 和的 碘乙烷亲核试剂已经被分为三个系列：（1）具有两个等效反应位点的亲核试剂，（2）在对位具有氯原子的亲核试剂，和（3）具有单个反应位点的亲核试剂。伴随的三种类型的部分去溶剂化过程激活根据这些分类推论得出。决定相对活性的主要因素甲基碘 到 碘乙烷 在一个具有单个反应位点的阴离子亲核试剂的取代反应中 乙腈（k MeI / k EtI）建议是从反应物到过渡态时亲核中心周围的部分去溶剂化。

表征谱图